Bayesian Capital Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Buy
+4,100
New +$299K 0.2% 144
2025
Q3
Sell
-4,773
Closed -$362K 848
2025
Q2
$362K Buy
+4,773
New +$338K 0.06% 351

Other funds holding SOLV

Bayesian Capital Management's SOLV Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Solventum (SOLV) in Q2 2026: 4,100 shares worth $316K. The stake represents 0.2% of the portfolio and ranks #144 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in SOLV as recently as Q2 2025.

Bayesian Capital Management first reported a position in SOLV in Q2 2025 and has held it in 2 quarters since. The position peaked at $362K in Q2 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Bayesian Capital Management held 4,100 shares of Solventum worth $316K as of Q2 2026.
  • Solventum was a new Bayesian Capital Management position in Q2 2026.
  • Solventum made up 0.2% of Bayesian Capital Management's portfolio in Q2 2026, its #144 holding.
  • Bayesian Capital Management first reported a position in Solventum in Q2 2025 and has held it in 2 quarters since.
  • Bayesian Capital Management's Solventum position peaked at $362K in Q2 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.